InVivo Therapeutics Holdings Corp

NASDAQ:NVIV   3:59:55 PM EDT
0.60
-0.06 (-8.66%)
Products

InVivo Therapeutics Announces FDA Acceptance Of Preclinical Module In Support Of Co’S Complete HDE Submission

Published: 07/13/2021 12:06 GMT
InVivo Therapeutics Holdings Corp (NVIV) - Invivo Therapeutics Announces FDA Acceptance of Preclinical Module in Support of Company’s Complete Hde Submission.